AMG 073: Phase II

Partner Amgen Inc. (AMGN, Thousand Oaks, Calif.) reported that in a 5-week U.S. Phase II trial in 10 PHPT

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE